These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 1646066

  • 1. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F, Perry DJ, Goutsou M, Modeas C, Muchmore E, Rege V, Chahinian AP, Hirsh V, Poiesz B, Green MR.
    Cancer; 1991 Jun 15; 67(12):2974-9. PubMed ID: 1646066
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O, Shevrin DH, Pandya KJ, Bonomi PD.
    Am J Clin Oncol; 2000 Aug 15; 23(4):371-5. PubMed ID: 10955866
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan 15; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 4. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP.
    J Clin Oncol; 1998 May 01; 16(5):1826-34. PubMed ID: 9586897
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec 01; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 7. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA, Hilton S, Mazumdar M, Sadan S, Heineman M, Hirsch J, Kelly WK, Scher HI, Bajorin DF.
    J Clin Oncol; 1997 Jun 01; 15(6):2449-55. PubMed ID: 9196161
    [Abstract] [Full Text] [Related]

  • 8. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Jun 01; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer.
    Johnson DH, Strupp J, Greco FA, Stewart J, Merrill W, Malcolm A, Hande KR, Hainsworth JD.
    Cancer; 1991 Sep 15; 68(6):1216-20. PubMed ID: 1651802
    [Abstract] [Full Text] [Related]

  • 10. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Sep 15; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 11. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin DB, Kim HT, Kim HJ.
    Cancer; 1993 Jun 15; 71(12):3813-8. PubMed ID: 8508349
    [Abstract] [Full Text] [Related]

  • 12. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
    Blumenreich MS, Woodcock TM, Gentile PS, Barnes GR, Jose B, Sherrill EJ, Richman SP, Epremian BE, Kubota TT, Allegra JC.
    J Clin Oncol; 1987 Nov 15; 5(11):1725-30. PubMed ID: 2824706
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.
    O'Dwyer PJ, Langer CJ, Walczak J, Levy MH, Padavic-Shaller K, Hudes GR, Litwin S, Comis RL.
    Eur J Cancer; 1991 Oct 15; 27(12):1589-93. PubMed ID: 1664216
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
    Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt WE, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, Stamatis G, Griesinger F, Thomas M, TREAT investigators.
    J Thorac Oncol; 2016 Jan 15; 11(1):85-93. PubMed ID: 26762743
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G, Gebbia V, Galetta D, Riccardi F, Cariello S, Gebbia N.
    Br J Cancer; 1997 Jan 15; 76(11):1509-17. PubMed ID: 9400950
    [Abstract] [Full Text] [Related]

  • 18. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
    Tummarello D, Graziano F, Isidori P, Santo A, Cetto G, Fedeli A, Rossi G, Cellerino R.
    Cancer; 1996 Jun 01; 77(11):2251-7. PubMed ID: 8635092
    [Abstract] [Full Text] [Related]

  • 19. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
    Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ, North Central Cancer Treatment Group.
    Am J Clin Oncol; 2001 Dec 01; 24(6):551-5. PubMed ID: 11801752
    [Abstract] [Full Text] [Related]

  • 20. A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
    Higano CS, Crowley J, Livingston RB, Goodwin JW, Barlogie B, Stuckey WJ.
    Cancer; 1991 May 15; 67(10):2439-42. PubMed ID: 1849785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.